• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[溶栓治疗后急性前壁梗死时的R-R间期变异性]

[R-R variability in acute anterior infarct after thrombolytic therapy].

作者信息

Boghossian S H, Maia I G, Costa Filho R, Alves P A

机构信息

Hospital Pró-Cardíaco, Rio de Janeiro.

出版信息

Arq Bras Cardiol. 1992 Nov;59(5):365-8.

PMID:1340735
Abstract

PURPOSE

To analyse the effects of thrombolysis on the integrity of the autonomic nervous system, in patient with acute myocardial infarction (AMI) of the anterior wall, using the determination of the heart rate variability.

METHODS

We prospectively evaluated the R-R variability of the 31 consecutive patients with anterior AMI submitted to coronary thrombolysis (25 males; mean age 59 +/- 14 years) from Holter tapes. An algorithm in a 286 computer program was used for heart rate variability (HRV). With this system, R-R variations during sinus rhythm and for a five consecutive minutes periods was determined. The results were expressed as the mean of the total determined periods; the standard deviation of the mean of all determined periods and the mean of the standard deviation. The reperfusion criteria was the early enzymatic rise of the CKMB activity levels (< or = 12 h) combined with a 50% or more reduction in the ST segment elevation within the first hour after thrombolytic therapy and the presence of an accelerated idioventricular rhythm at the same time. The reperfused group (group 1 = 16 patients) and non-reperfused group (group 2 = 15 patients) were compared in terms of R-R variability.

RESULTS

Mean R-R: group 1 = 716 +/- 84 ms (540-820 ms); group 2 = 595 +/- 115 ms (390-870 ms)-p < 0.02. ms (34-92 ms); group 2 = 50 +/- 14 ms (23-77 ms)-p < 0.01. HRV 50 ms: group 1 = 2 patients; group 2 = 5 patients. Means SD of the R-R: group 1 = 44 +/- 14 ms (26-65 ms); group 2 = 39 +/- 17 ms (19-69 ms)-p: ns.

CONCLUSION

Patients with anterior AMI and thrombolytic therapy demonstrate greater HRV; this finding suggested better integrity of the autonomic nervous system, with possible effects on prognosis.

摘要

目的

通过测定心率变异性,分析溶栓治疗对前壁急性心肌梗死(AMI)患者自主神经系统完整性的影响。

方法

我们前瞻性评估了31例接受冠状动脉溶栓治疗的连续性前壁AMI患者(25例男性;平均年龄59±14岁)动态心电图记录的RR间期变异性。使用286计算机程序中的一种算法来测定心率变异性(HRV)。通过该系统,测定窦性心律期间以及连续5分钟时段的RR间期变化。结果以所有测定时段的平均值、所有测定时段平均值的标准差以及标准差的平均值表示。再灌注标准为CKMB活性水平早期酶学升高(≤12小时),同时溶栓治疗后第一小时内ST段抬高降低50%或更多,且同时存在加速性室性自主心律。比较再灌注组(第1组 = 16例患者)和未再灌注组(第2组 = 15例患者)的RR间期变异性。

结果

平均RR间期:第1组 = 716±84毫秒(540 - 820毫秒);第2组 = 595±115毫秒(390 - 870毫秒) - p < 0.02。毫秒(34 - 92毫秒);第2组 = 50±14毫秒(23 - 77毫秒) - p < 0.01。HRV 50毫秒:第1组 = 2例患者;第2组 = 5例患者。RR间期的平均标准差:第1组 = 44±)14毫秒(26 - 65毫秒);第2组 = 39±17毫秒(19 - 69毫秒) - p:无显著差异。

结论

接受溶栓治疗的前壁AMI患者表现出更大的HRV;这一发现提示自主神经系统完整性更好,可能对预后有影响。

相似文献

1
[R-R variability in acute anterior infarct after thrombolytic therapy].[溶栓治疗后急性前壁梗死时的R-R间期变异性]
Arq Bras Cardiol. 1992 Nov;59(5):365-8.
2
[Effects of reperfusion and coronary reocclusion on the variability of heart rate in patients with acute myocardial infarction].[再灌注及冠状动脉再闭塞对急性心肌梗死患者心率变异性的影响]
Cardiologia. 1999 Feb;44(2):181-6.
3
[The variability of the heart rate in the first 24 hours after fibrinolytic therapy in acute myocardial infarct].[急性心肌梗死溶栓治疗后最初24小时内心率的变异性]
Rev Port Cardiol. 1999 Mar;18(3):261-5.
4
[Changes in autonomic control of heart rate after ischemic cerebral stroke].[缺血性脑卒中后心率自主控制的变化]
Acta Med Croatica. 2003;57(4):269-73.
5
[Study of heart rate variability in acute myocardial infarction and its relationship with ventricular function and other clinical variables].急性心肌梗死患者心率变异性及其与心室功能和其他临床变量关系的研究
Rev Esp Cardiol. 1996 Jan;49(1):29-34.
6
[Twenty-four hour heart rate variability in patients with acute myocardial infarction depending on treatment].急性心肌梗死患者24小时心率变异性与治疗的关系
Pol Merkur Lekarski. 1997 Feb;2(8):107-8.
7
Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.急性心肌梗死中阿替普酶(50毫克)联合替罗非班溶栓与单独使用阿替普酶(100毫克)溶栓的安全性和有效性:初步研究结果。
Ital Heart J. 2001 Aug;2(8):605-11.
8
[The frequency of early coronary reperfusion assessed by electrocardiographic criteria in relation to the timing of thrombolytic therapy in acute myocardial infarct].
Minerva Cardioangiol. 1992 Mar;40(3):65-9.
9
Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.国产重组链激酶治疗急性心肌梗死的临床试验。国产重组链激酶溶栓协作研究组。
Chin Med J (Engl). 1997 Jan;110(1):50-2.
10
Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.急性心肌梗死中加速输注链激酶可使梗死相关动脉获得更好的心肌梗死溶栓治疗(TIMI)血流分级。
Indian Heart J. 2000 Jan-Feb;52(1):40-4.